VivoSim Labs, Inc. Professional Fees
VivoSim Labs, Inc. (VIVS) reported Professional Fees of $39.60 thousand for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-01-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2012-01-17
- VivoSim Labs, Inc. professional fees for the quarter ending 2011-12-31 was $39.60K, a 54.72% increase year-over-year.
- VivoSim Labs, Inc. professional fees for the quarter ending 2011-09-30 was $22.50K, a 5.59% decline year-over-year.
- VivoSim Labs, Inc. professional fees for the quarter ending 2010-12-31 was $25.59K.
- VivoSim Labs, Inc. professional fees for the quarter ending 2010-09-30 was $23.83K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 21 month | Professional Fees 24 month |
|---|---|---|---|---|
| 2011-12-31 | $39.60K 10-Q · filed 2012-01-17 | $62.10K 10-Q · filed 2012-01-17 | $185.50K 10-Q · filed 2012-01-17 | |
| 2011-09-30 | $22.50K 10-Q · filed 2011-10-31 | $145.91K 10-Q · filed 2011-10-31 | ||
| 2010-12-31 | $25.59K 10-Q · filed 2012-01-17 | $49.42K 10-Q · filed 2012-01-17 | ||
| 2010-09-30 | $23.83K 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |